HighTower Advisors
PGEN icon

HighTower Advisors’s Precigen PGEN Stock Holding History

HighTower Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,000
Closed -$200 – 3603
2022
Q4 		$200 Hold
1,000
– – ﹤0.01% 3317
2022
Q3 		$18K Buy
+1,000
New +$2.11K ﹤0.01% 2981
2022
Q1 		– Sell
-1,000
Closed -$23K – 3624
2021
Q4 		$23K Sell
1,000
-99,000
-99% -$426K ﹤0.01% 3096
2021
Q3 		$78K Buy
+100,000
New +$576K ﹤0.01% 2877

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HighTower Advisors's PGEN Position: Q2 2026 in Review

HighTower Advisors reduced its Precigen (PGEN) stake by 15% in Q2 2026, selling an estimated $73.1K and leaving 97,242 shares worth $554K. The position accounts for ﹤0.01% of the portfolio, ranked #2661.

HighTower Advisors first reported a position in PGEN in Q1 2014 and has held it in 47 quarters since. The position peaked at $3.94M in Q3 2018. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • HighTower Advisors held 97,242 shares of Precigen worth $554K as of Q2 2026.
  • HighTower Advisors sold 16,910 Precigen shares in Q2 2026, an estimated $73.1K.
  • Precigen made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #2661 holding.
  • HighTower Advisors first reported a position in Precigen in Q1 2014 and has held it in 47 quarters since.
  • HighTower Advisors's Precigen position peaked at $3.94M in Q3 2018.
  • 210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.